Joint Formulary & PAD

Dupilumab - Chronic rhinosinusitis with nasal polyps

You are here : Home > Formulary Search > Dupilumab - Chronic rhinosinusitis with nasal polyps

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
NHSE
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Dupilumab
Indication :
Chronic rhinosinusitis with nasal polyps
Group Name :
Keywords :
Brand Names Include :
Dupixent
Important Information :

For allergy specialists only

Latest Additions Date From :
17 Mar 2026
Latest Additions Date To :
17 Apr 2026
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Dupilumab is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Chronic rhinosinusitis with nasal polyps.

  • No records returned.